Satellos Bioscience Inc (MSLE)

$11.25 -0.66 (-5.54%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 105,000
Avg Vol 15,576
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 39%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a li...

Industry: Biotechnology
Sector: Healthcare
Address:
Royal Bank Plaza, Suite 2800 South Tower 200 Bay Street, Toronto, Canada
PennyScam
PennyScam Jun. 24 at 2:05 PM
$MSLE I think you are smart DG. Good play. Ck
1 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Jun. 22 at 5:57 PM
$MSLE bought back in today
0 · Reply
PennyScam
PennyScam Jun. 13 at 3:40 PM
$MSLE Soon Greasy G. Soon……
0 · Reply
Gatorgunk
Gatorgunk Jun. 3 at 5:27 PM
$CAPR anyone in here also in $MSLE ?
3 · Reply
PennyScam
PennyScam May. 29 at 1:21 PM
$MSLE HEY Puppet Gleeson. You talking to Daniel Teper? You talking to Immune or Naya yet? How about Astra Zeneca you fucking dweeb? Ck
0 · Reply
Merlintrader
Merlintrader May. 15 at 2:58 PM
$TRAW Viral Threats, Liver Fibrosis and Muscle Regeneration: $TRAW, $GALT and $MSLE Add Another Layer to the May 15 Biotech Tape https://www.merlintrader.com/viral-threats-may2026-update/
0 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 4:54 PM
$MSLE
0 · Reply
nnnuuu
nnnuuu Apr. 30 at 5:01 PM
$MSLE fly my little shitco penny stock DMD company, fly!
1 · Reply
PennyScam
PennyScam Apr. 29 at 1:24 PM
$MSLE That’s good for ICO Therapeutics holders. Awesome. Crazy K
0 · Reply
nnnuuu
nnnuuu Apr. 28 at 8:04 PM
$MSLE $23
0 · Reply
Latest News on MSLE
Satellos resumed with a Speculative Buy at Canaccord

2026-05-21T11:18:01.000Z - 5 weeks ago

Satellos resumed with a Speculative Buy at Canaccord

Satellos reports Q1 EPS (53c), consensus (59c)

2026-05-15T12:06:36.000Z - 5 weeks ago

Satellos reports Q1 EPS (53c), consensus (59c)

Satellos initiated with a Buy at Guggenheim

2026-04-28T11:00:43.000Z - 2 months ago

Satellos initiated with a Buy at Guggenheim

Satellos initiated with an Outperform at Leerink

2026-04-06T10:41:27.000Z - 2 months ago

Satellos initiated with an Outperform at Leerink

Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright

2026-03-30T10:21:50.000Z - 3 months ago

Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright

Cantor starts Satellos with an Overweight on DMD therapy potential

2026-03-11T12:00:38.000Z - 3 months ago

Cantor starts Satellos with an Overweight on DMD therapy potential

Satellos initiated with an Overweight at Cantor Fitzgerald

2026-03-11T10:31:41.000Z - 3 months ago

Satellos initiated with an Overweight at Cantor Fitzgerald

Satellos Bioscience Inc. Common Stock trading resumes

2026-03-10T14:10:13.000Z - 3 months ago

Satellos Bioscience Inc. Common Stock trading resumes

Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause

2026-03-10T14:05:15.000Z - 3 months ago

Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause

Satellos presents interim SAT-3247 data at MDA Conference

2026-03-10T11:22:01.000Z - 3 months ago

Satellos presents interim SAT-3247 data at MDA Conference

Satellos price target raised to $40 from $5 at Oppenheimer

2026-02-10T13:12:15.000Z - 4 months ago

Satellos price target raised to $40 from $5 at Oppenheimer

Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Feb 6, 2026, 8:30 AM EST - 4 months ago

Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Satellos Bioscience IPO Registration Document (F-10)

Feb 5, 2026, 4:09 PM EST - 5 months ago

Satellos Bioscience IPO Registration Document (F-10)

PennyScam
PennyScam Jun. 24 at 2:05 PM
$MSLE I think you are smart DG. Good play. Ck
1 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Jun. 22 at 5:57 PM
$MSLE bought back in today
0 · Reply
PennyScam
PennyScam Jun. 13 at 3:40 PM
$MSLE Soon Greasy G. Soon……
0 · Reply
Gatorgunk
Gatorgunk Jun. 3 at 5:27 PM
$CAPR anyone in here also in $MSLE ?
3 · Reply
PennyScam
PennyScam May. 29 at 1:21 PM
$MSLE HEY Puppet Gleeson. You talking to Daniel Teper? You talking to Immune or Naya yet? How about Astra Zeneca you fucking dweeb? Ck
0 · Reply
Merlintrader
Merlintrader May. 15 at 2:58 PM
$TRAW Viral Threats, Liver Fibrosis and Muscle Regeneration: $TRAW, $GALT and $MSLE Add Another Layer to the May 15 Biotech Tape https://www.merlintrader.com/viral-threats-may2026-update/
0 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 4:54 PM
$MSLE
0 · Reply
nnnuuu
nnnuuu Apr. 30 at 5:01 PM
$MSLE fly my little shitco penny stock DMD company, fly!
1 · Reply
PennyScam
PennyScam Apr. 29 at 1:24 PM
$MSLE That’s good for ICO Therapeutics holders. Awesome. Crazy K
0 · Reply
nnnuuu
nnnuuu Apr. 28 at 8:04 PM
$MSLE $23
0 · Reply
Weightgainclyde
Weightgainclyde Apr. 28 at 3:31 PM
$MSLE this is the quietest board on the planet
1 · Reply
PennyScam
PennyScam Apr. 18 at 8:06 PM
$MSLE Have you looked at the value of your wholly owned ICO subsidiary? Great value here. Crazy K
1 · Reply
Florestan
Florestan Apr. 17 at 2:16 AM
$MSLE ;)
0 · Reply
spaceodyssey2001
spaceodyssey2001 Apr. 16 at 7:16 PM
$MSLE So whether it’s updated TRAILHEAD data in a few months or top-line BASECAMP data before year-end, we feel investors will return to Satellos, and the stock will rebound.
1 · Reply
WBinthehouse
WBinthehouse Apr. 16 at 4:29 PM
$MSLE up 9% on 35k shares. lol
0 · Reply
WBinthehouse
WBinthehouse Apr. 13 at 5:16 PM
$MSLE up 10% on 76k shares. Anemic. Can’t even get out if need be lol.
1 · Reply
PennyScam
PennyScam Apr. 13 at 5:13 AM
$MSLE Neither am I. Ck
0 · Reply
WBinthehouse
WBinthehouse Apr. 11 at 5:44 AM
$MSLE got cut in half from high after RS. Not surprised.
0 · Reply
viber7
viber7 Apr. 10 at 3:39 PM
$MSLE risk analysis.
1 · Reply
focafoca99
focafoca99 Apr. 9 at 7:54 PM
$MSLE is previewing its appearance at the Bloom Burton healthcare conference.
0 · Reply
spaceodyssey2001
spaceodyssey2001 Apr. 8 at 11:50 PM
$MSLE Leerink Partners $20 Buy 221% Upside Initiated 04/06/26 H.C. Wainwright $11 Buy 77% Upside Reiterated 03/30/26 Cantor Fitzgerald $52 NPV Buy 732% Upside Initiated 03/11/26 Leede Financial $16 Buy 157% Upside Reiterated 03/11/26 Oppenheimer $40 Buy 542% Upside Reiterated 02/25/26 Canaccord - outdated
0 · Reply
spaceodyssey2001
spaceodyssey2001 Apr. 8 at 11:48 PM
$MSLE
0 · Reply